Autor:	Clara Hwang, Lamia Aljundi, Nichole Miller, Jonathan Hung, Andrew Taylor
Rok vydání:	2016
Předmět:	Oncology Cancer Research medicine.medical_specialty business.industry Castration resistant urologic and male genital diseases medicine.disease Prostate cancer Docetaxel Castration Resistance Internal medicine medicine business medicine.drug
Zdroj:	Journal of Clinical Oncology. 34:e16519-e16519
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2016.34.15_suppl.e16519
Popis:	e16519Background: Castration resistant prostate cancer (CRPC) continues to present a challenge for oncologists. There is renewed interest in the use of docetaxel in advanced prostate cancer; howeve...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::7ff735ea27a624646301d0b3ee45b25d https://doi.org/10.1200/jco.2016.34.15_suppl.e16519 Zobrazit plný text záznamu